Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Use of Cleaning Agents in Sterile Equipment Cleaning – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Use of Cleaning Agents in Sterile Equipment Cleaning – V 2.0

Standard Operating Procedure for Use of Cleaning Agents in Sterile Equipment Cleaning


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/152/2025
Supersedes SOP/SIM/152/2022
Page No. Page 1 of 13
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

To define a standard and compliant procedure for the selection, preparation, use, and rotation of cleaning agents used in the cleaning of equipment and accessories in sterile injectable manufacturing areas, ensuring effectiveness in

removing residues and maintaining a contamination-free environment.

2. Scope

This SOP applies to all cleaning personnel and operators involved in the preparation and use of cleaning agents for cleaning and sanitizing manufacturing equipment, utensils, and contact surfaces in aseptic, solution preparation, and dispensing areas of the sterile injectable facility.

3. Responsibilities

  • Production Operator: Prepares and uses cleaning agents as per instructions.
  • Sanitation Personnel: Executes cleaning activities and records details in logs.
  • Quality Control: Tests efficacy of cleaning agents periodically.
  • Quality Assurance: Verifies records, approves cleaning agent lists, and audits practices.
See also  Sterile Injectable Manufacturing: SOP for Operation of Lyophilizers in Injectable Production - V 2.0

4. Accountability

Head of Production and Head of QA are jointly accountable for ensuring proper use of validated cleaning agents as per this SOP and GMP regulations.

5. Procedure

5.1 Approved Cleaning Agents

  1. Use only QA-approved cleaning agents listed in the approved Cleaning Agent Master List (Annexure-1).
  2. Common cleaning agents:
    • Alkaline cleaner (e.g., 1% sodium hydroxide)
    • Acidic cleaner (e.g., 1% phosphoric acid)
    • Non-ionic detergent (e.g., enzymatic agents)
    • Disinfectants (e.g., 70% IPA, QAC-based)

5.2 Preparation of Cleaning Agents

  1. Prepare cleaning agents using purified water or WFI as per instruction sheets/SDS.
  2. Preparation must be done in a dedicated area with appropriate PPE.
  3. Label solution containers with:
    • Name of cleaning agent
    • Concentration
    • Date/time of preparation
    • Prepared by
    • Expiry date/time (as per stability)
  4. Record preparation details in Cleaning Agent Logbook (Annexure-2).

5.3 Rotation of Cleaning Agents

  1. Implement rotation policy to prevent microbial resistance buildup.
  2. Maintain a rotation schedule approved by QA (Annexure-3).
  3. Ensure minimum two different classes of disinfectants rotated weekly or monthly.

5.4 Application Method

  1. Apply agents using lint-free cloths, spray bottles, or automated CIP systems depending on surface and equipment.
  2. Follow contact time as specified by manufacturer or validation study (e.g., 10 minutes for QAC, 30 seconds for IPA).
  3. After contact time, rinse if applicable or allow to air dry.
See also  Sterile Injectable Manufacturing: SOP for Monitoring Batch Yield during Injectable Production - V 2.0

5.5 Documentation

  1. Document each cleaning activity including:
    • Name and concentration of cleaning agent used
    • Equipment cleaned
    • Time and date
    • Performed by and verified by signatures
  2. Maintain records in Equipment Cleaning Log (Annexure-4).

5.6 Handling and Storage

  1. Store cleaning agents in designated chemical storage areas with temperature control.
  2. All containers must be properly closed, labeled, and stored away from raw materials or drug products.

5.7 Disposal

  1. Expired or unused cleaning agents must be discarded as per hazardous waste SOPs.
  2. Document disposal in Cleaning Agent Disposal Log (Annexure-5).

6. Abbreviations

  • SOP: Standard Operating Procedure
  • PPE: Personal Protective Equipment
  • QA: Quality Assurance
  • QC: Quality Control
  • IPA: Isopropyl Alcohol
  • QAC: Quaternary Ammonium Compound
  • WFI: Water for Injection

7. Documents

  1. Annexure-1: Cleaning Agent Master List
  2. Annexure-2: Cleaning Agent Preparation Log
  3. Annexure-3: Cleaning Agent Rotation Schedule
  4. Annexure-4: Equipment Cleaning Log
  5. Annexure-5: Cleaning Agent Disposal Log

8. References

  • ICH Q7 Good Manufacturing Practice Guidelines
  • EU GMP Annex 1: Manufacture of Sterile Medicinal Products
  • WHO TRS 961
  • 21 CFR Part 211
See also  Quality Assurance: SOP for Risk Mitigation Strategies in QA Activities - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Sanitation Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Cleaning Agent Master List

Cleaning Agent Type Concentration Approved By
IPA Disinfectant 70% Sunita Reddy
QAC Disinfectant 1% Sunita Reddy
Sodium Hydroxide Alkaline Cleaner 1% Sunita Reddy

Annexure-2: Cleaning Agent Preparation Log

Date Agent Concentration Prepared By Expiry
22/06/2025 QAC 1% Ravi Joshi 23/06/2025

Annexure-3: Cleaning Agent Rotation Schedule

Week Primary Agent Alternate Agent Verified By
Week 1 QAC IPA QA
Week 2 IPA QAC QA

Annexure-4: Equipment Cleaning Log

Date Equipment ID Agent Used Cleaned By Checked By
22/06/2025 VL-05 IPA Suresh Kumar QA

Annexure-5: Cleaning Agent Disposal Log

Date Agent Quantity Disposed By Witnessed By
22/06/2025 QAC 2 Litres Anita Sharma QA

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial release New SOP QA Head
24/06/2025 2.0 Updated rotation policy and annexures Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Analytical Method Development: SOP for Analytical Method for Extractables from Packaging – V 2.0
Next Post: Top 10 FDA 483 Citations Linked to Poor SOP Documentation

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version